Randomized Controlled Trial on Conventional Vs Tailored Limb Lengths in Laparoscopic Roux-en Y Gastric Bypass Surgery

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The study aims to investigate whether tailoring limb lengths based on the 1/3rd and 2/3rd concept improves clinical outcomes in Laparoscopic Roux-en-Y Gastric Bypass (LRYGB) surgery compared to conventional limb lengths. In this study, two groups were described, first group involves patients who will undergo Lap RYGB with conventional limb lengths of 75cms and 125cms, while the second group is given tailored limb lengths according to the total small bowel length. In the follow up period, Total percentage weight loss, improvement in BMI along with the remission of co-morbidities were also assessed.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:

• Age: 18-65 years

• Body Mass Index (BMI):

• BMI ≥ 40 kg/m² or BMI ≥ 35 kg/m² with at least one obesity-related comorbidity (e.g., type 2 diabetes, hypertension, obstructive sleep apnea).

• ASA - less than or equal to 3

• Informed Consent: Ability and willingness to provide written informed consent and comply with procedures.

• Previous Weight Loss Attempts: Documentation of previous attempts at weight loss through diet, exercise, or medical management.

Locations
Other Locations
India
GEM Hospital and Research Center
RECRUITING
Coimbatore
Time Frame
Start Date: 2024-04-01
Estimated Completion Date: 2025-12
Participants
Target number of participants: 40
Treatments
Placebo_comparator: Conventional group
In this arm, standard limb lengths of 75cms BP limb and 125cms Alimentary limb were measured and performed, irrespective of the total bowel length
Active_comparator: Tailored group
In this arm, limb lengths are tailored according to the total small bowel length, 1/3rd of the total bowel length is measured and in that 3/8th and 5/8th were kept as BP limb and alimentary limb respectively.
Related Therapeutic Areas
Sponsors
Leads: GEM Hospital & Research Center

This content was sourced from clinicaltrials.gov